Growth Metrics

Palisade Bio (PALI) Share-based Compensation Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -34.72%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 4.80%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 10.78%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.55%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 20.65%
10 Palisade Bio 439.25 Mn 309.68 Mn - 258.67%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 258.67%
Dec 31, 2025 251.10%
Sep 30, 2025 -30.39%
Jun 30, 2025 -43.69%
Mar 31, 2025 -45.80%
Dec 31, 2024 -38.28%
Sep 30, 2024 -3.69%
Jun 30, 2024 -36.79%
Mar 31, 2024 -53.56%
Dec 31, 2023 8.84%
Sep 30, 2023 -33.87%
Jun 30, 2023 -28.44%
Mar 31, 2023 7.01%
Dec 31, 2022 -10.37%
Sep 30, 2022 -5.07%
Jun 30, 2022 37.67%
Mar 31, 2022 1.94%
Dec 31, 2021 120.38%
Sep 30, 2021 -8.55%
Jun 30, 2021 36.01%
Mar 31, 2021 33.56%
Dec 31, 2020 20.92%
Sep 30, 2020 26.28%
Jun 30, 2020 -15.53%
Mar 31, 2020 -47.43%
Dec 31, 2019 -40.90%
Sep 30, 2019 -20.16%
Jun 30, 2019 -45.98%
Mar 31, 2019 -38.75%
Dec 31, 2018 -57.48%
Sep 30, 2018 -44.90%
Jun 30, 2018 -32.01%
Mar 31, 2018 -29.78%
Dec 31, 2017 -26.92%
Sep 30, 2017 -20.53%
Jun 30, 2017 6.41%
Mar 31, 2017 -40.18%
Dec 31, 2016 32.17%
Sep 30, 2016 -16.87%
Jun 30, 2016 11.05%
Mar 31, 2016 45.58%
Dec 31, 2015 25.19%
Sep 30, 2015 18.27%
Jun 30, 2015 23.70%
Mar 31, 2015 23.05%
Dec 31, 2014 14.11%
Sep 30, 2014 -0.54%
Jun 30, 2014 -20.04%
Mar 31, 2014 28.57%
Dec 31, 2013 -42.20%
Sep 30, 2013 -8.42%